Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives
- 8 June 2010
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (15), 4624-4626
- https://doi.org/10.1016/j.bmcl.2010.06.005
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Reviews Of Anti‐infective Agents: New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in CoverageClinical Infectious Diseases, 2006
- Antifungal Therapy: Lessons Learned over the Past 27 YearsClinical Infectious Diseases, 2006
- Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasisInternational Journal of Antimicrobial Agents, 2006
- Voriconazole: therapeutic review of a new azole antifungalExpert Review of Anti-infective Therapy, 2004
- Antifungal agents: mechanisms of actionTrends in Microbiology, 2003
- In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important FungiAntimicrobial Agents and Chemotherapy, 2000
- In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346)Antimicrobial Agents and Chemotherapy, 1998
- Synthesis and Antifungal Activity of Novel Thiazole-Containing Triazole Antifungals. II. Optically Active ER-30346 and Its Derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1998
- Epidemiology of nosocomial fungal infectionsClinical Microbiology Reviews, 1996
- Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatusBioorganic & Medicinal Chemistry Letters, 1996